|
|
|
Insider
Information: |
Miller Richard A Md |
Relationship: |
Director |
City: |
Sunnyvale |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
893,366 |
|
Indirect Shares
|
1,214,771 |
|
|
Direct
Value |
$3,175,136 |
|
|
Indirect Value
|
$6,510,804 |
|
|
Total
Shares |
2,108,137 |
|
|
Total
Value |
$9,685,940 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
6
|
0
|
Stock
price went up :
|
4
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
Percentage
Gain/Loss : |
123.2%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Pharmacyclics Inc |
PCYC |
Pres, CEO & Director, ... |
2007-08-22 |
300,130 |
2007-08-22 |
26,668 |
Premium* |
|
Corvus Pharmaceuticals, Inc. |
CRVS |
|
2024-05-10 |
577,634 |
2024-05-10 |
1,188,103 |
Premium* |
|
Bolt Biotherapeutics, Inc. |
BOLT |
Director |
2021-02-04 |
15,602 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
48 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 2
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BOLT |
Bolt Biotherapeutics, Inc... |
Director |
|
2021-02-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
15,602 |
|
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEOOfficer |
|
2016-03-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
718,228 |
|
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2016-03-29 |
4 |
A |
$0.00 |
$0 |
I/I |
328,765 |
1,046,993 |
0 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2016-05-12 |
4 |
B |
$10.00 |
$300,000 |
I/I |
30,000 |
1,076,993 |
2.66 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2016-05-13 |
4 |
B |
$9.94 |
$2,981 |
I/I |
300 |
1,077,293 |
2.58 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2016-10-28 |
5 |
GD |
$0.00 |
$0 |
I/I |
100,000 |
977,293 |
0 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2017-06-09 |
4 |
B |
$9.89 |
$87,174 |
I/I |
8,784 |
986,077 |
2.66 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2017-06-12 |
4 |
B |
$9.82 |
$110,185 |
I/I |
11,216 |
997,293 |
2.66 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2017-06-13 |
4 |
B |
$9.75 |
$49,725 |
I/I |
5,000 |
1,002,293 |
2.66 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2017-11-20 |
4 |
B |
$10.79 |
$107,850 |
I/I |
10,000 |
1,012,293 |
2.66 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2018-03-12 |
4 |
B |
$8.50 |
$850,000 |
I/I |
100,000 |
1,112,293 |
2.66 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2018-12-04 |
4 |
B |
$5.95 |
$8,937 |
I/I |
1,502 |
1,113,795 |
2.58 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2018-12-06 |
4 |
B |
$5.99 |
$29,934 |
I/I |
5,000 |
1,118,795 |
2.66 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2018-12-11 |
4 |
GD |
$0.00 |
$0 |
I/I |
20,000 |
1,098,795 |
0 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2018-12-20 |
4 |
B |
$4.39 |
$43,950 |
I/I |
10,000 |
1,108,795 |
2.66 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2018-12-27 |
4 |
B |
$3.29 |
$65,884 |
I/I |
20,000 |
1,128,795 |
2.66 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2019-06-07 |
4 |
B |
$3.37 |
$31,019 |
I/I |
9,212 |
1,138,007 |
2.66 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2019-06-11 |
4 |
B |
$3.67 |
$22,020 |
I/I |
6,000 |
1,144,007 |
2.58 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2019-06-13 |
4 |
B |
$3.52 |
$1,207 |
I/I |
343 |
1,144,350 |
2.58 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2019-06-14 |
4 |
B |
$3.40 |
$39,666 |
I/I |
11,657 |
1,156,007 |
2.66 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2019-08-06 |
4 |
B |
$3.58 |
$17,875 |
I/I |
5,000 |
1,161,007 |
2.58 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2019-08-07 |
4 |
B |
$3.54 |
$8,850 |
I/I |
2,500 |
1,163,507 |
2.58 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2019-11-12 |
4 |
B |
$2.90 |
$789 |
I/I |
272 |
1,163,779 |
2.58 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2019-11-13 |
4 |
B |
$3.00 |
$44,240 |
I/I |
14,736 |
1,178,515 |
2.66 |
- |
|
CRVS |
Corvus Pharmaceuticals, I... |
President and CEO |
|
2021-02-17 |
4 |
B |
$3.50 |
$350,000 |
I/I |
100,000 |
1,278,515 |
2.66 |
- |
|
48 Records found
|
|
Page 1 of 2 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|